These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22795543)

  • 21. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
    Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
    Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles.
    Mohammad Gholinia Sarpoli L; Zare-Karizi S; Heidari E; Hasanzadeh A; Bayandori M; Azedi F; Hamblin MR; Karimi M
    Pharm Dev Technol; 2022 Sep; 27(7):785-793. PubMed ID: 36043390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer.
    Wang K; Guo C; Dong X; Yu Y; Wang B; Liu W; Chen D
    Mol Pharm; 2018 Jul; 15(7):2764-2769. PubMed ID: 29792799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
    Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
    Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
    Mukerjee A; Ranjan AP; Vishwanatha JK
    J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
    Clementi C; Miller K; Mero A; Satchi-Fainaro R; Pasut G
    Mol Pharm; 2011 Aug; 8(4):1063-72. PubMed ID: 21608527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate.
    Pignatello R; Cenni E; Micieli D; Fotia C; Salerno M; Granchi D; Avnet S; Sarpietro MG; Castelli F; Baldini N
    Nanomedicine (Lond); 2009 Feb; 4(2):161-75. PubMed ID: 19193183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
    Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
    Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
    J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
    Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
    Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
    Mukerjee A; Vishwanatha JK
    Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alendronate conjugated nanoparticles for calcification targeting.
    Li N; Song J; Zhu G; Shi X; Wang Y
    Colloids Surf B Biointerfaces; 2016 Jun; 142():344-350. PubMed ID: 26970822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
    J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration.
    Chakraborti M; Jackson JK; Plackett D; Brunette DM; Burt HM
    Int J Pharm; 2011 Sep; 416(1):305-13. PubMed ID: 21708236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodistribution of antisense nanoparticles in mammary carcinoma rat model.
    Elazar V; Adwan H; Rohekar K; Zepp M; Lifshitz-Shovali R; Berger MR; Golomb G
    Drug Deliv; 2010 Aug; 17(6):408-18. PubMed ID: 20429847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.